George W. Sledge
Director/Board Member at Tessa Therapeutics Ltd
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Metzger | M | 53 | 9 years | |
| Andrew Khoo | M | - |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Thomas Willemsen | M | - |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 2 years |
| Göran Albert Ando | M | 75 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 6 years |
| Gabriela Gruia | M | 67 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 3 years |
| Michael Snyder | M | - |
Stanford University School of Medicine
| 15 years |
| Keith Katkin | M | 52 | 7 years | |
| Pierre Legault | M | 63 | 7 years | |
| Luke Albrecht | M | 45 | 8 years | |
| Ivan D. Horak | M | 73 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 5 years |
| Simon Stertzer | M | 88 |
Stanford University School of Medicine
| 26 years |
| Bruno C. Medeiros | M | - |
Stanford University School of Medicine
| - |
| Philip Hanno | M | - |
Stanford University School of Medicine
| 8 years |
| Fidah Alsagoff | M | - |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Joseph Wolk | M | 57 |
Stanford University School of Medicine
| - |
| Gunawan Lim | M | - |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Vikram Bajaj | M | 46 |
Stanford University School of Medicine
| 10 years |
| Paula T. Trzepacz | M | - |
The Indiana University School of Medicine
| 20 years |
| Calvin J. Kuo | M | - |
Stanford University School of Medicine
| - |
| Walter Greenleaf | M | - |
Stanford University School of Medicine
| 7 years |
| Mark A. Kay | M | 66 |
Stanford University School of Medicine
| 26 years |
| Alejandro Dorenbaum | M | 64 |
Stanford University School of Medicine
| - |
| Halim Susanto | M | 57 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Oliver Dorigo | M | - |
Stanford University School of Medicine
| - |
| Hannah Valantine | M | 72 |
Stanford University School of Medicine
| 37 years |
| John W. Day | M | - |
Stanford University School of Medicine
| 13 years |
| Phil Yang | M | - |
Stanford University School of Medicine
| - |
| Tzee Penn Ng | M | 47 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 8 years |
| Mintu Turakhia | M | 50 |
Stanford University School of Medicine
| 16 years |
| Jennifer Rosingana | F | - |
Stanford University School of Medicine
| - |
| Chris Zeise | M | - |
Stanford University School of Medicine
| - |
| Christi Opitz | F | - |
Stanford University School of Medicine
| - |
| Judith Ned | F | - |
Stanford University School of Medicine
| - |
| Susan Hoerger | F | - |
Stanford University School of Medicine
| - |
| Stefan Heller | M | 58 |
Stanford University School of Medicine
| - |
| Gary Berke | M | - |
Stanford University School of Medicine
| - |
| Henry Greely | M | - |
Stanford University School of Medicine
| - |
| Kiki Chang | M | - |
Stanford University School of Medicine
| - |
| Anjali Ganguli | M | 48 | 9 years | |
| Glenn Matthew Chertow | M | - |
Stanford University School of Medicine
| - |
| Ryan Spitler | M | - |
Stanford University School of Medicine
| 8 years |
| Sandra Horning | M | 75 |
Stanford University School of Medicine
| - |
| Thomas C. Südhof | M | 68 |
Stanford University School of Medicine
| - |
| Theodore Tussing | M | - |
Stanford University School of Medicine
| - |
| Lucy Shapiro | M | 83 |
Stanford University School of Medicine
| 35 years |
| Emmett Cunningham | M | 63 |
Stanford University School of Medicine
| 16 years |
| David Karpf | M | 69 |
Stanford University School of Medicine
| - |
| Joseph Wu | M | - |
Stanford University School of Medicine
| 11 years |
| George Tidmarsh | M | 64 |
Stanford University School of Medicine
| 14 years |
| Eugene Bauer | M | 81 |
Stanford University School of Medicine
| 36 years |
| Ramon Chavez Márquez | M | 60 |
Stanford University School of Medicine
| 9 years |
| Peter Fitzgerald | M | 66 |
Stanford University School of Medicine
| 27 years |
| Michelle Brandt | F | - |
Stanford University School of Medicine
| - |
| Lawrence Steinman | M | 76 |
Stanford University School of Medicine
| - |
| Edgar Engleman | M | 78 |
Stanford University School of Medicine
| 34 years |
| Paul A. Berg | M | 97 |
Stanford University School of Medicine
| - |
| Steven J. Chu | M | 76 |
Stanford University School of Medicine
| 11 years |
| Wai Shun Cheung | M | 55 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 2 years |
| Peter Kim | M | 65 |
Stanford University School of Medicine
| 10 years |
| Christopher Viehbacher | M | 64 |
Stanford University School of Medicine
| - |
| Daria Mochly-Rosen | M | - |
Stanford University School of Medicine
| - |
| Sachie Oshima | M | 52 |
Stanford University School of Medicine
| 17 years |
| Paul Blumenthal | M | - |
Stanford University School of Medicine
| - |
| Stephen Galli | M | 77 |
Stanford University School of Medicine
| 25 years |
| William J. Maloney | M | - |
Stanford University School of Medicine
| 20 years |
| Eddie C. Cheung | M | - |
Stanford University School of Medicine
| - |
| Jeffrey Glenn | M | 61 |
Stanford University School of Medicine
| 24 years |
| K. Christopher Garcia | M | - |
Stanford University School of Medicine
| 25 years |
| Jillian Manus | F | - |
Stanford University School of Medicine
| 6 years |
| Emmet B. Keeffe | M | - |
Stanford University School of Medicine
| - |
| James Newman | M | - |
Stanford University School of Medicine
| - |
| Thomas Krummel | M | 72 |
Stanford University School of Medicine
| - |
| Roger Kornberg | M | 76 |
Stanford University School of Medicine
| 46 years |
| Amato Giaccia | M | 65 |
Stanford University School of Medicine
| - |
| Thomas Raffin | M | 77 |
Stanford University School of Medicine
| - |
| Lawrence M. Shuer | M | - |
Stanford University School of Medicine
| - |
| Terrence Blaschke | M | 81 |
Stanford University School of Medicine
| 50 years |
| Garry Nolan | M | 63 |
Stanford University School of Medicine
| - |
| James Gillespie | M | - |
Stanford University School of Medicine
| 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Shea | M | 72 | 6 years | |
| Allan Shaw | M | 59 | 1 years | |
| Tzee Penn Ng | M | 48 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | 7 years |
| Briggs Morrison | M | 65 | 9 years | |
| John S. Pallies | M | 60 | 9 years | |
| Jeffrey H. Buchalter | M | 67 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Alexander Nolte | M | 52 | 6 years | |
| Arlene Morris | F | 72 | 4 years | |
| Jerry W. Smartt | M | - |
The Indiana University School of Medicine
| 3 years |
| Henry Chen | M | 53 | 3 years | |
| Michael Meyers | M | 74 | 7 years | |
| Ivor Royston | M | 79 | 4 years | |
| Kim Kamdar | M | 56 | 11 years | |
| Steven F. Isenberg | M | - |
The Indiana University School of Medicine
| 2 years |
| Yasmeen Rahimi | M | - |
The Indiana University School of Medicine
| 3 years |
| Marti Arvin | F | - |
The Indiana University School of Medicine
| 3 years |
| Ming-Kian Teo | M | 72 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | - |
| Rakesh Patel | M | 50 |
The Indiana University School of Medicine
| 4 years |
| Hua Qiong Shen | M | 62 |
The Indiana University School of Medicine
| 3 years |
| Jon Barada | M | - |
The Indiana University School of Medicine
| 3 years |
| Zach Berwick | M | - |
The Indiana University School of Medicine
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 87 | 87.00% |
| Singapore | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- George W. Sledge
- Personal Network
